Explore the latest in neuroimaging, including new functional technologies and imaging markers of dementia, depression, ALS, and more.
This cross-sectional study compares synaptic vesicle glycoprotein 2A binding in the brains of participants with Alzheimer disease and cognitively normal participants using positron emission tomographic (PET) imaging.
This cohort study investigates the spatiotemporal distribution and pathomechanisms of white matter hyperintensities in patients with reversible cerebral vasoconstriction syndrome.
This imaging substudy of a randomized clinical trial investigates whether infarction patterns can be used to stratify the risk of recurrent stroke within 3 months of a transient ischemic attack or minor ischemic stroke.
This longitudinal study assesses whether vascular risk and β-amyloid burden act additively or synergistically to promote cognitive decline in clinically normal older adults.
This cross-sectional study investigates the extent and the role of tau in patients with subcortical vascular cognitive impairment using 18F-AV1451, which is a new ligand to detect neurofibrillary tangles in vivo.
This multicenter cohort study evaluates the ability of flutemetamol F 18 and other biomarkers to assess the risk of progression from amnestic mild cognitive impairment to probable Alzheimer disease.
This imaging study quantifies the association between neuroimaging measures and behavioral, health, and demographic variables in psychosis using an integrated multivariate approach.
This longitudinal study examines the association of age, β-amyloid levels, and the apolipoprotein E ε4 allele with memory decline in a large group of cognitively healthy older adults enrolled in the Australian Imaging, Biomarkers, and Lifestyle study.
This study examines the association between reperfusion and brain edema in patients with acute ischemic stroke.
This study examines whether acute brain lesions on diffusion-weighted imaging are related to delayed neurological sequelae after carbon monoxide poisoning.
This study investigates the association of the top 20 Alzheimer disease risk variants with brain amyloidosis.
An adolescent boy presented with cognitive and behavioral changes, headaches, and progressively worsening weakness of the left arm and leg. On magnetic resonance imaging, a lesion in the right basal ganglia discovered 16 months previously appeared larger. What is your diagnosis?
This Viewpoint disambiguates correlational evidence in neuroimaging studies from research that determines causation and suggests ways to use both to improve psychiatric care.
This cross-sectional analysis among participants from the Offspring cohort of the Framingham Study assesses the association between prevalent nonalcoholic fatty liver disease and brain magnetic resonance imaging measures.
This prospective longitudinal study investigates the neurodevelopmental trajectory of the association between early childhood adversity and adolescent general and emotional health outcomes.
A teenage Chinese girl with intermittent limp and increasing headache was admitted to our the hospital in December 2016. A brain magnetic resonance imaging showed multiple parenchymal lesions, involving the pons, bilateral amygdala, and the left temporal pole. What is your diagnosis?
This longitudinal observational study determines if the combination of smell identification testing followed by dopamine transporter imaging can accurately and efficiently identify individuals from the general population at risk for conversion to a clinical diagnosis of Parkinson disease.
Customize your JAMA Network experience by selecting one or more topics from the list below.